Abbott Laboratories (Pakistan) Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was PKR 11,771.16 million compared to PKR 9,890.79 million a year ago. Revenue was PKR 11,771.16 million compared to PKR 9,890.79 million a year ago. Net income was PKR 1,441.78 million compared to PKR 1,442.49 million a year ago. Basic earnings per share from continuing operations was PKR 14.73 compared to PKR 14.73 a year ago.